is tirzepatide or semaglutide better for pcos PCOS? The Potential Utility of Tirzepatide

25 The SURMOUNT-1 trial for tirzepatide (Zepbound) reported that fat mass decreased significantly (33-36%), while lean mass decreased by about 10-11%

This multi-pathway approach - enhancing central access, synergizing at neuronal targets, and activating complementary energy expenditure pathways - provides a more robust physiological foundation than GLP-1 mono-agonism, justifying the stronger clinical evidence and the higher confidence in its substantial efficacy profile

Does compulsive behavior in Anorexia Nervosa resemble an addiction

Most side effects, like nausea, are temporary and manageable

Ipamorelin shows less receptor desensitization than some comparable compounds in extended preclinical protocols GH responsiveness holds up over time in a way that matters for studies running weeks rather than days